Showing results (191-200 of 251) with videos related to

Sort By:
Pageof 26
American Journal of Clinical Pathology|January 1, 1980
A clinically applicable high-pressure liquid chromatographic method for measurement of serum theophylline, with detailed evaluation of interferencesN Weidner, D N Dietzler, J H Ladenson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 28, 1980
Adaptation of the EMIT theophylline assay to kinetic analyzers: the relationship of reaction kinetics to calculation proceduresD N Dietzler, N Weidner, V L Tieber, et al.
The British Journal of Dermatology|June 20, 2014
Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort studyC L Martyn-Simmons, W M C Rosenberg, R Cross, et al.
The British Journal of Dermatology|June 1, 1996
Eosinophil infiltration into human skin is antigen-dependent in the late-phase reactionT M Litchfield, C H Smith, B A Atkinson, et al.
Immunogenetics|January 8, 2010
Characterization of the zebrafish T cell receptor beta locusNathan D Meeker, Alexandra C H Smith, J Kimble Frazer, et al.
Investigative Ophthalmology & Visual Science|April 28, 2006
T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantificationEyal Banin, Michael I Dorrell, Edith Aguilar, et al.
Analytical Chemistry|July 15, 1996
Laser desorption/ionization time-of-flight mass spectrometry of nitrated polycyclic aromatic hydrocarbonsR N Dotter, C H Smith, M K Young, et al.
The Bone & Joint Journal|December 3, 2013
The treatment of stable paediatric forearm fractures using a cast that may be removed at home: comparison with traditional management in a randomised controlled trialT W Hamilton, L Hutchings, J Alsousou, et al.
The British Journal of Dermatology|March 17, 2001
A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitisL C Fuller, C H Smith, R Cerio, et al.
The British Journal of Dermatology|June 24, 2006
Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label studyC H Smith, K Jackson, S J Bashir, et al.
Pageof 26